Terms: = Uterine cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Prognosis
3 results:
1. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
Shi K; Liu XL; Guo Q; Zhang YQ; Fan ST; Dai L; Jiang N; Li D
PLoS One; 2023; 18(7):e0285817. PubMed ID: 37478120
[TBL] [Abstract] [Full Text] [Related]
2. High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.
Lu X; Ying Y; Zhang W; Li R; Zhang J
Cell Biol Int; 2023 Jan; 47(1):201-215. PubMed ID: 36208091
[TBL] [Abstract] [Full Text] [Related]
3. Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
Santoro A; Angelico G; Travaglino A; Raffone A; Arciuolo D; D'Alessandris N; Inzani F; Zannoni GF
Gynecol Oncol; 2021 May; 161(2):629-635. PubMed ID: 33712277
[TBL] [Abstract] [Full Text] [Related]
